Sir Richard Henry Treisman (born 7 October 1954)[6] is a British scientist specialising in the molecular biology of cancer. Treisman is a director of research at the Francis Crick Institute in London.
He showed that the TCF family of SRF cofactors are targets for Mitogen-activated protein kinase (MAPK) signalling, and demonstrated that the MRTF transcription cofactors are novel G-actin binding proteins that sense fluctuations in G-actin concentration. He continues to focus on SRF's regulatory cofactors and their cognate signalling pathways.[8]
^ abAnon (1994). "Richard Treisman". royalsociety.org. London: Royal Society. Archived from the original on 27 October 2017. Retrieved 27 May 2018. One or more of the preceding sentences incorporates text from the royalsociety.org website where: